par 164
Pill imprint par 164 has been identified as Benztropine mesylate 0.5 mg.
Benztropine is used in the treatment of parkinson's disease; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Benztropine 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Benztropine mesylate Images
- Imprint:
-
par 164
- Strength:
- 0.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
lactose monohydrate
microcrystalline cellulose
starch
magnesium silicate
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0164
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00182-1299 | Goldline Laboratories Inc |
| 00904-1055 | Major Pharmaceuticals |
| 63739-0033 | McKesson Packaging Services |
| 68115-0826 | Dispensexpress Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Benztropine Mesylate resources
- Benztropine (Wolters Kluwer)
- Benztropine Tablets (Wolters Kluwer)
- benztropine (Cerner Multum)
- benztropine (Micromedex) - Includes Dosage Information
- benztropine Injection (Micromedex) - Includes Dosage Information
- Benztropine Mesylate (AHFS DI)
- Benztropine (FDA)
- Benztropine Injection (FDA)
- Benztropine Mesylate (Wolters Kluwer)
Search Again
